Lam 2002.
Clinical features and settings | Routine screening | |
Participants | 16,237 participants undergoing NT and biochemical testing Hong Kong ‐ multi‐centre study 1997 to 2000 Pregnant women Mean maternal age 30.5 years (19% > 35 years) 10‐14 weeks and 15‐18 weeks' gestation |
|
Study design | Prospective cohort | |
Target condition and reference standard(s) | Down's syndrome: 35 cases Reference standards: women considered high risk offered CVS (0.7%) or amniocentesis (11.8%). Follow‐up to birth |
|
Index and comparator tests | Maternal age First trimester NT (FMF methods) Second trimester free ßhCG and AFP (methods not reported) |
|
Follow‐up | By review of hospital and laboratory records and by directly telephoning women. Participants who defaulted the second trimester serum tests (n = 1015) and those who miscarried after NT but before serum testing (n = 91) were excluded from the study. Outcome obtained in 15,253 patients (93.9%) | |
Aim of study | To report data on participants undergoing both first and second trimester methods of screening to assess the relative efficacy of different methods of screening | |
Test characteristics | ||
Reference standard used | ||
Notes | ||
Table of Methodological Quality | ||
Item | Authors' judgement | Description |
Representative spectrum? All tests | Yes | Routine screening of typical pregnant population |
Acceptable reference standard? All tests | Yes | Karyotyping or follow‐up to birth |
Partial verification avoided? All tests | Unclear | Unclear if all women received a reference standard |
Differential verification avoided? All tests | No | Choice of reference standard depended on index test results |
Incorporation avoided? All tests | Yes | Reference standard was independent of the index test |
Reference standard results blinded? All tests | No | Reference standard interpreted with knowledge of index test results |
Index test results blinded? All tests | Yes | Index test interpreted without knowledge of reference standard results |
Relevant clinical information? All tests | Yes | Information available as would be in standard clinical practice |
Uninterpretable results reported? All tests | Yes | NT successful in 99.8% of cases |
Withdrawals explained? All tests | Yes | Details given for patients excluded and those without follow‐up data |